$0.785
+0.031 (+3.91%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CRDF por análisis de gráficos similares
Alphio's CRDF stock price prediction model matches the current Cardiff Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.80 (+0.15%). The 1-week path is $0.75 (-5.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Cardiff Oncology Inc?
Currently, Cardiff Oncology Inc (CRDF) is not a strong buy due to its low current price of $0.8443 and a 52-week change of -61.97%. The RSI is at 33.314, indicating it is nearing oversold territory, which could suggest a potential for recovery. However, the company has reported significant net losses, with a net income of -9.24 million in Q2 2026, and a forward P/E ratio of 0, which raises concerns about profitability. The main risk is the ongoing legal dispute affecting its lead drug candidate, which could impact future revenue and stock performance.
CRDF cerró en $0.78 el Friday, tras subir +3.91%
Cardiff Oncology Inc (CRDF) last closed at $0.7953, gaining +5.30%. These facts feed the 1-day and 1-week CRDF price prediction above.
Factores de la previsión
Los factores de la previsión de Cardiff Oncology Inc (CRDF) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CRDF, ordenadas por similitud.
Análisis de estacionalidad de CRDF
Historically the probability of a positive November return for CRDF is 45.45%. February offers the highest probability of a positive month at 53.45%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CRDF
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $3.32 | $3.35 | $3.53 | +321.37% |
| Dec 2026 | $2.97 | $3.35 | $3.61 | +321.37% |
En 2026, se proyecta que Cardiff Oncology Inc (CRDF) oscile entre $2.97 y $3.61.
Previsión mensual de Cardiff Oncology Inc para 2026
En Nov de 2026, se proyecta que Cardiff Oncology Inc promedie $3.35, con un mínimo de $3.32 y un máximo de $3.53.
En Dec de 2026, se proyecta que Cardiff Oncology Inc promedie $3.35, con un mínimo de $2.97 y un máximo de $3.61.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.